References
- Bellio P., Fagnani L., Nazzicone L., Celenza G.: New and simplified method for drug combination studies by checkerboard assay. MethodsX, 8, 101543 (2021)
- Brennan-Krohn T., Kirby J.E.: When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing. Clin. Lab. Med. 39, 345–358 (2019a)
- Brennan-Krohn T., Kirby J.E.: Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method. J.Vis. Exp. 146, 10.3791/58636 (2019b)
- Brennan-Krohn T., Truelson K.A., Smith K.P., Kirby J.E.: Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology. J. Antimicrob. Chemother. 72, 2775–2781 (2017)
- Doern C.D.: When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J. Clin. Microbiol. 52, 4124–8 (2014)
- https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Break point_tables/v_14.0_Breakpoint_Tables.pdf EUCAST. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, valid from 2024-01-01. 19.05.2024
- https://atlas.ecdc.europa.eu/public/index.aspx. European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases, 13.04.2024
- Fatsis-Kavalopoulos N., Roemhild R., Tang P.-C., Kreuger J., Andersson D.I.: CombiANT: Antibiotic interaction testing made easy, PLOS Biol. 18, e3000856 (2020)
- Gaudereto J.J., Neto L.V.P., Leite G.C., Espinoza E.P.S., Martins R.C.R., Prado G.V.B., Rossi F., Guimarães T., Levin A.S., Costa S.F.: Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria. BMC Microbiol. 20, 97 (2020)
- Garbusińska A., Szliszka E.: Aktywność leków przeciwdrobno-ustrojowych zastosowanych w kombinacjach wobec pałeczek Gram-ujemnych w badaniach in vitro. Post. N. Med., XXX(08), 427–433 (2017)
- Guzek A.: Metodologia oznaczania synergizmu między antybio-tykami z zastosowaniem pasków z gradientem stężeń antybio-tyków w warunkach in vitro. Forum Zakażeń, 14, 19–24 (2023)
- Karakonstantis S., Ioannou P., Kofteridis D.D.: In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations. Infection, 50, 569–581 (2022)
- Laishram S., Pragasam A.K., Bakthavatchalam Y.D., Veerara-ghavan B.: An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J. Med. Microbiol. 35, 445–468 (2017)
- Marie M.A.M., Krishnappa L.G., Alzahrani A.J., Mubaraki M.A., Alyousef A.A.: A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii. Bosn. J. Basic Med. Sci. 15, 24–29 (2015)
- Nasomsong W., Nulsopapon P., Changpradub D., Pungcharoen-kijkul S., Hanyanunt P., Chatreewattanakul T., Santimaleeworagun W.: Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbape-nem-Resistant Pseudomonas aeruginosa. Antibiotics (Basel), 11, 517 (2022)
- Okoliegbe I.N., Hijazi K., Cooper K., Ironside C., Gould I.M.: Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics (Basel), 10, 967 (2021)
- Papoutsaki V., Galani I., Papadimitriou E., Karantani I., Karaiskos I., Giamarellou H.: Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates. J. Global Antimicrob. Resist. 20, 98–104 (2020)
- https://pharmaceutical-journal.com/article/news/only-12-new-antibiotics-entered-the-market-in-five-years-who-warns-in-review Sayburn A.: Only 12 new antibiotics entered the market in five years, WHO warns in review. The Pharmaceutical Journal, 310 (2023), 04.12.2024
- Sreenivasan P., Sharma B., Kaur S., Rana S., Biswal M., Ray P., Angrup A.: In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era. J. Antibiot. (Tokyo), 75, 454–462 (2022)
- Tang P.-C., Sánchez-Hevia D.L., Westhoff S., Fatsis-Kavalopoulos N., Andersson D.I.: Within-species variability of antibiotic interactions in Gram-negative bacteria. mBio, 15, e0019624 (2024)
- https://iris.who.int/bitstream/handle/10665/354545/9789240047655-eng.pdf?sequence=1. WHO. World Health Organization: 2021 Antibacterial agents in clinical and preclinical development: an overview and analysis, 13.04.2024
- https://antybiotyki.edu.pl/wp-content/uploads/Biuletyn/Biuletyn-Informacyjny-2_2022.pdf Żabicka D., Grzegorczyk M.: Oporność na antybiotyki w Polsce i Europie w 2021 roku-dane sieci EARS-Net. Oporność na antybiotyki. Biuletyn informacyjny, 2 (2022), 19.05.2024